Determination of sensitivity to antibiotics of Campilobacter jejuni and Campilobacter coli isolated from human feces
Author(s) -
Zoran Tambur,
Biljana Miljković-Selimović,
Dubravko Bokonjić
Publication year - 2009
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0901049t
Subject(s) - campylobacteriosis , microbiology and biotechnology , campylobacter jejuni , campylobacter , ampicillin , campylobacter coli , ciprofloxacin , erythromycin , tetracycline , chloramphenicol , nalidixic acid , biology , antibiotic sensitivity , antibiotics , antibiotic resistance , bacteria , genetics
One of the most important bacterial zoonosis is campylobacteriosis. Human disease is mostly caused by thermophilic Campylobacter spp: Campylobacter jejuni (C. jejuni), Campylobacter coli (C. coli), Campylobacter lari (C. lari) and Campylobacter upsakensis (Campsalensis). Campylobacteriosis is a mild and self-healing disorder. In patients with more severe and prolonged forms, an antibiotic treatment is recommended. Recommended drugsare erythromycin, ciprofloxacin, tetracyclin, chloramphenicol and ampicillin. Lately, an increase of Campylobacter genus resistance to antibiotics mostly used in therapy is an annoying evidence. The rise coincided with the beginning of antibiotic use, especially quinolones, in veterinary medicine. The aim of the study was to isolate and identify thermophilic Campylobacter spp. from human feces and to determine their sensitivity to antibiotics and hemotherapeutics mostly used in campylobacteriosis treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom